Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A comprehensive clinical review of romosozumab's safety and efficacy differences in East Asian patients, covering pharmacogenomics, ethnicity-stratified trial data, cardiovascular signal interpretation, and dosing considerations.
Read clinical reviewA clinical review of romosozumab efficacy differences in Hispanic and Latino patients, covering ethnicity-stratified trial subgroup data, pharmacogenomics, diabetes-related bone phenotypes, and what prescribers should monitor.
Read clinical reviewDoes romosozumab require dose adjustments for Hispanic or Latino patients? Review the pharmacology, trial subgroup data, and clinical guidance for Evenity dosing across populations.
Read clinical reviewEvidence-based review of romosozumab (Evenity) safety, efficacy, and pharmacogenomic considerations specific to Black and African ancestry patients, including cardiovascular risk data and dosing guidance.
Read clinical reviewEvidence-based review of romosozumab efficacy in South Asian populations, including pharmacogenomic factors, dosing considerations, bone density response data, and cardiovascular risk context.
Read clinical review